Company / SG&A per Share
Serina Therapeutics, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.31
FY2025
5-year range
$0.16 / $3.61
FY2021-FY2025
Trend
-19.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 7 years, ranging from $0.16 in FY2022 to $3.61 in FY2023.
Based on SEC 10-K filings.
1.31 in FY2025 with a 5-year CAGR of +43.3%.
Improved from $3.61 to $1.31 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +102.5%
- 5-Year CAGR
- +43.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 19.1% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.31 | -19.1% |
| FY2024 | $1.62 | -55.2% |
| FY2023 | $3.61 | +2193.2% |
| FY2022 | $0.16 | -11.6% |
| FY2021 | $0.18 | -17.7% |
| FY2020 | $0.22 | +29.2% |
| FY2018 | $0.17 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026